Stryker Corporation (NYSE:SYK – Get Free Report) shares reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $327.27 and last traded at $328.4550, with a volume of 173290 shares trading hands. The stock had previously closed at $332.59.
Stryker News Summary
Here are the key news stories impacting Stryker this week:
- Positive Sentiment: Stryker says the cybersecurity incident has been contained and the company is making progress restoring systems, which reduced near-term operational uncertainty and supported a positive market reaction. Stryker Addresses and Contains Recent Cybersecurity Incident
- Positive Sentiment: Media reports noted shares rose after the company said the incident was contained, indicating investor relief on reduced immediate disruption risk. Stryker shares climb after company says cybersecurity incident contained
- Positive Sentiment: Stryker reports restoration efforts are progressing and operations are stabilizing — a key sign for revenue continuity and supply-chain recovery. Stryker reports progress in restoration efforts after cyberattack, operations continue to stabilize
- Neutral Sentiment: Corporate housekeeping: Stryker announced its 2026 Annual Meeting of Shareholders — standard timeline item with little immediate financial impact. Stryker announces Annual Meeting of Shareholders
- Neutral Sentiment: Analyst pieces compare Stryker vs. peers (Envista, Intuitive Surgical) on value and growth — useful context for positioning but not immediate catalysts. Investors may re-assess relative valuation and robotics exposure versus peers. NVST or SYK: Which Is the Better Value Stock Right Now? Intuitive Surgical vs. Stryker: Which Surgical Tech Stock Leads?
- Negative Sentiment: Security risk remains material: reporting highlights that attackers (including state-linked groups) are focusing on enterprise systems to disrupt operations and extract leverage — raising the chance of longer-term reputational, regulatory and remediation costs for Stryker. This ongoing threat is likely behind continued caution among investors. Stryker Cyberattack Highlights Criminal Focus on Enterprise Systems
- Negative Sentiment: Stryker notified regulators (SEC) about the incident earlier in March; potential follow-on disclosures, costs, or operational impacts could still emerge and weigh on the stock until the company quantifies any material effects. Stryker Addresses and Contains Recent Cybersecurity Incident
Wall Street Analysts Forecast Growth
Several research analysts recently commented on the stock. Truist Financial reduced their price objective on shares of Stryker from $400.00 to $392.00 and set a “hold” rating for the company in a research note on Thursday, December 18th. Jefferies Financial Group reiterated a “buy” rating and set a $465.00 price objective on shares of Stryker in a report on Wednesday, March 4th. Piper Sandler restated an “overweight” rating on shares of Stryker in a research note on Tuesday, January 27th. Wall Street Zen upgraded Stryker from a “hold” rating to a “buy” rating in a research note on Saturday, February 21st. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Stryker in a report on Monday, December 22nd. Fourteen research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $427.50.
Stryker Price Performance
The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.21 and a current ratio of 1.89. The stock’s 50 day simple moving average is $362.68 and its two-hundred day simple moving average is $365.29. The firm has a market capitalization of $125.93 billion, a PE ratio of 39.17, a price-to-earnings-growth ratio of 1.96 and a beta of 0.85.
Stryker (NYSE:SYK – Get Free Report) last announced its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, topping analysts’ consensus estimates of $4.40 by $0.07. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The firm had revenue of $7.17 billion for the quarter, compared to the consensus estimate of $7.12 billion. During the same quarter last year, the business posted $4.01 earnings per share. The firm’s revenue was up 11.4% compared to the same quarter last year. On average, sell-side analysts forecast that Stryker Corporation will post 13.47 EPS for the current year.
Stryker Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be paid a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. Stryker’s payout ratio is 41.90%.
Insider Buying and Selling at Stryker
In other news, Director Ronda E. Stryker sold 250,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the sale, the director owned 2,457,331 shares in the company, valued at $891,814,566.52. This trade represents a 9.23% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 5.20% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Stryker
Hedge funds have recently modified their holdings of the business. Norges Bank purchased a new stake in Stryker in the fourth quarter valued at approximately $1,822,272,000. Alliancebernstein L.P. raised its holdings in Stryker by 307.6% in the second quarter. Alliancebernstein L.P. now owns 5,596,508 shares of the medical technology company’s stock valued at $2,214,146,000 after acquiring an additional 4,223,366 shares in the last quarter. Auto Owners Insurance Co lifted its position in shares of Stryker by 35,047.0% during the 4th quarter. Auto Owners Insurance Co now owns 2,914,741 shares of the medical technology company’s stock worth $1,024,444,000 after purchasing an additional 2,906,448 shares during the last quarter. Wellington Management Group LLP grew its stake in shares of Stryker by 22.6% during the fourth quarter. Wellington Management Group LLP now owns 6,493,276 shares of the medical technology company’s stock worth $2,282,192,000 after purchasing an additional 1,198,665 shares in the last quarter. Finally, Corient Private Wealth LLC increased its holdings in Stryker by 104.4% in the second quarter. Corient Private Wealth LLC now owns 2,245,841 shares of the medical technology company’s stock valued at $887,525,000 after buying an additional 1,146,998 shares during the last quarter. 77.09% of the stock is currently owned by hedge funds and other institutional investors.
About Stryker
Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.
See Also
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.
